Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Johnson Controls International | JCI | 6. jan 2025 | 79.27 | -0.81 |
Johnson Outdoors A | JOUT | 6. jan 2025 | 35.60 | +3.94 |
Joint Stock Company Kaspi.kz | KSPI | 6. jan 2025 | 97.69 | -1.19 |
Jones Lang LaSalle | JLL | 6. jan 2025 | 256.29 | +0.92 |
Journey Medical | DERM | 6. jan 2025 | 4.34 | +1.88 |
Jowell Global | JWEL | 6. jan 2025 | 3.07 | +4.07 |
JOYY ADR | YY | 6. jan 2025 | 38.50 | -1.21 |
JP Morgan Chase | JPM | 6. jan 2025 | 240.85 | -1.00 |
JP Morgan Chase & Co EE Pref | JPM-C | 6. jan 2025 | 25.45 | -0.08 |
JP Morgan Chase & Co GG Pref | JPM-J | 6. jan 2025 | 21.48 | -0.60 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | 6. jan 2025 | 25.20 | -0.28 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | 6. jan 2025 | 57.61 | +0.93 |
Jumia Technologies ADR | JMIA | 6. jan 2025 | 4.15 | +5.06 |
Junee Limited - Ordinary Shares | JUNE | 6. jan 2025 | 3.64 | -0.27 |
Junior Gold Miners ETF Market Vectors | GDXJ | 6. jan 2025 | 43.79 | -1.04 |
Juniper Networks | JNPR | 6. jan 2025 | 37.98 | +0.08 |
Jupiter Neurosciences | JUNS | 6. jan 2025 | 8.75 | 0.00 |
JVSPAC Acquisition | JVSA | 6. jan 2025 | 10.43 | 0.00 |
JVSPAC Acquisition | JVSAU | 6. jan 2025 | 10.66 | 0.00 |
JX Luxventure | JXG | 6. jan 2025 | 1.09 | 0.00 |
JX Luxventure | JXJT | 6. jan 2025 | 0.81 | 0.00 |
Kadant | KAI | 6. jan 2025 | 353.89 | +0.54 |
Kairos Pharma | KAPA | 6. jan 2025 | 1.57 | +1.29 |
Kairous Acquisition | KACL | 6. jan 2025 | 12.33 | 0.00 |
Kaiser Aluminium | KALU | 6. jan 2025 | 70.25 | +0.03 |
Kaival Brands Innovations Group | KAVL | 6. jan 2025 | 0.87 | -4.94 |
Kaixin Holdings | KXIN | 6. jan 2025 | 1.63 | +0.62 |
Kala Bio | KALA | 6. jan 2025 | 7.53 | -5.04 |
Kaltura | KLTR | 6. jan 2025 | 2.58 | -7.19 |
KalVista Pharmaceuticals | KALV | 6. jan 2025 | 8.68 | -3.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.